<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101233170</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32527</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Metab.</journal-id>
<journal-title-group>
<journal-title>Cell metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">1550-4131</issn>
<issn pub-type="epub">1932-7420</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29514064</article-id>
<article-id pub-id-type="pmc">6342515</article-id>
<article-id pub-id-type="doi">10.1016/j.cmet.2018.02.011</article-id>
<article-id pub-id-type="manuscript">NIHMS945421</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Therapeutic potential of NAD-boosting molecules: the <italic>in vivo</italic> evidence</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rajman</surname>
<given-names>Luis</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chwalek</surname>
<given-names>Karolina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sinclair</surname>
<given-names>David A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">#</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Paul F. Glenn Center for the Biological Mechanisms of Aging, Department of Genetics, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="A2">
<label>2</label>Laboratory for Ageing Research, Department of Pharmacology, School of Medical Sciences, The University of New South Wales, Sydney NSW 2052, Australia</aff>
<author-notes>
<corresp id="FN1"><label>#</label>Lead contact and correspondence to: <email>david_sinclair@hms.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>06</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>529</fpage>
<lpage>547</lpage>
<!--elocation-id from pubmed: 10.1016/j.cmet.2018.02.011-->
<abstract id="Abs1">
<title>Summary</title>
<p id="P1">Nicotinamide adenine dinucleotide (NAD), the cell’s hydrogen carrier for redox enzymes, is well known for its role in redox reactions. More recently, it has emerged as a signaling molecule. By modulating NAD<sup>+</sup> sensing enzymes, it controls hundreds of key processes from energy metabolism to cell survival, rising and falling depending on food intake, exercise and the time of day. NAD<sup>+</sup> levels steadily decline with age, resulting in altered metabolism and increased disease susceptibility. Restoration of NAD<sup>+</sup> levels in old or diseased animals can promote health and extend lifespan, prompting a search for safe and efficacious NAD-boosting molecules. Such molecules hold the promise of increasing the body’s resilience, not just to one disease, but to many, thereby extending healthy human lifespan.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>eTOC Blurb</title>
<p id="P2">Nicotinamide adenine nucleotide (NAD+) has emerged as a key regulator of cellular processes that control the body’s response to stress. Rajman et al. discuss NAD boosters, small molecules that raise NAD+ levels, which are now considered to be highly promising for the treatment of multiple diseases and the potential extension of human lifespan.</p>
</abstract>
<kwd-group>
<kwd>aging</kwd>
<kwd>epigenetics</kwd>
<kwd>sirtuins</kwd>
<kwd>chromatin</kwd>
<kwd>epigenetics</kwd>
<kwd>PARP1</kwd>
<kwd>cancer</kwd>
<kwd>cardiovascular disease</kwd>
<kwd>inflammation</kwd>
<kwd>nicotinamide riboside</kwd>
<kwd>nicotinamide mononucleotide</kwd>
<kwd>CD38</kwd>
<kwd>STAC</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>